Trial Profile
Efficacy and safety of nab-paclitaxel plus carboplatin in patients with Carcinoma of unknown primary site
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 10 Mar 2015
Price :
$35
*
At a glance
- Drugs Carboplatin (Primary) ; Paclitaxel (Primary)
- Indications Carcinoma
- Focus Therapeutic Use
- 10 Mar 2015 New trial record